Dopamine D3-D2 receptor heterodimer (D3R-D2R heterodimer)

The Human dopamine D3-D2 receptor heterodimer is a functional protein complex formed by the physical association of dopamine D3 and D2 receptor protomers, both of which are members of the D2-like G protein-coupled receptor (GPCR) family (Scarselli et al., 2001). These heterodimers are primarily localized in the brain's limbic and striatal regions, where they play a pivotal role in modulating dopaminergic neurotransmission, motor control, and reward-related behaviors (Maggio et al., 2003). Research indicates that the D3-D2 heteromer possesses unique pharmacological and signaling properties that differ from its constituent homomers, such as synergistic or antagonistic interactions in ligand binding and G-protein coupling (Marcellino et al., 2008). In clinical contexts, these complexes are implicated in the pathophysiology of schizophrenia, Parkinson's disease, and substance use disorders, making them significant targets for neuropsychiatric drug development (UniProt P14416, P35462). Many existing antipsychotics and dopamine agonists, such as cariprazine and pramipexole, interact with both D2 and D3 receptors, and their therapeutic efficacy may be mediated through these heteromeric assemblies (PubChem CID 11957468). Targeting the specific interface or unique conformational states of the D3-D2 heterodimer offers a potential strategy for developing more selective therapies with reduced side effects, such as extrapyramidal symptoms or impulse control issues.

Other names

D2-D3 heteromerDopamine D2/D3 receptor complexD3-D2 receptor complexHuman dopamine D3/D2 receptor heterodimerD2R-D3R heterodimerDRD3-DRD2 heterodimer

Drugs targeting the D3-D2 receptor heterodimer typically act as agonists, partial agonists, or antagonists that modulate the Gi/o-mediated inhibition of adenylyl cyclase and the recruitment of beta-arrestin, often exploiting the unique allosteric interactions between the two receptor subunits to achieve specific therapeutic effects in the central nervous system (Maggio et al., 2003; Marcellino et al., 2008).